Clincosm LogoSign in Get a demo

pancreatic adenocarcinoma metastatic

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Pancreatic Adenocarcinoma Metastatic
  • Scottsdale, Arizona
    Clinical Trials Nurse Navigator
Oct 3, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

Not yet recruiting
  • Pancreatic Adenocarcinoma Metastatic
    • Pessac, France
      CHU Bordeaux
    Aug 17, 2023

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Recurrent Trial in Italy (Decitabine 50 MG [Dacogen])

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • Pancreatic Adenocarcinoma Recurrent
    • Decitabine 50 MG [Dacogen]
    • Milano, Italy
    • +5 more
    Jul 13, 2022

    Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Adenocarcinoma Metastatic
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jun 7, 2022

    Pancreatic Adenocarcinoma Non-resectable, Pancreatic Adenocarcinoma Metastatic, Colorectal Cancer Metastatic Trial in New York

    Completed
    Has Results
    • Pancreatic Adenocarcinoma Non-resectable
    • +2 more
    • RENCA macrobeads
    • New York, New York
      Weill Cornell Medical Center / The Rogosin Institute
    Apr 23, 2021

    Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Locally Advanced, Pancreatic Adenocarcinoma Metastatic Trial in

    Completed
    • Pancreatic Adenocarcinoma Resectable
    • +2 more
    • Edegem, Antwerpen, Belgium
    • +1 more
    Sep 2, 2020

    Pancreatic Adenocarcinoma Metastatic Trial in Indianapolis (Cabozantinib 40 MG, Erlotinib 100Mg Tab)

    Terminated
    Has Results
    • Pancreatic Adenocarcinoma Metastatic
    • Cabozantinib 40 MG
    • Erlotinib 100Mg Tab
    • Indianapolis, Indiana
    • +1 more
    Aug 17, 2020

    Pancreatic Adenocarcinoma Metastatic Trial in El Segundo (NANT-008, Fluorouracil Injectable Product, Avastin Injectable Product)

    Suspended
    • Pancreatic Adenocarcinoma Metastatic
    • El Segundo, California
      Chan Soon-Shiong Institutes for Medicine
    Jun 15, 2020

    Pancreatic Adenocarcinoma Metastatic, Ovarian Serous Adenocarcinoma, Colorectal Cancer Metastatic Trial in Cambridge

    Completed
    • Pancreatic Adenocarcinoma Metastatic
    • +2 more
    • Cambridge, United Kingdom
      Addenbrookes Hospital
    Jul 19, 2019

    Pancreatic Adenocarcinoma Metastatic Trial in United Kingdom (Abraxane (nab-paclitaxel), Gemcitabine)

    Completed
    • Pancreatic Adenocarcinoma Metastatic
    • Cambridge, Cambridgeshire, United Kingdom
    • +22 more
    Jul 15, 2019

    Pancreatic Adenocarcinoma Metastatic, Chemo Effect Trial in Hangzhou (Sequential Treatment)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • Chemotherapy Effect
    • Sequential Treatment
    • Hangzhou, Zhejiang, China
      The second affiliated hospital of Zhejiang University
    Aug 20, 2018

    Pancreatic Adenocarcinoma Metastatic Trial in France (ERY001, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox))

    Completed
    • Pancreatic Adenocarcinoma Metastatic
    • Avignon, France
    • +15 more
    Jul 25, 2018